V002-0923 Screening compound: N-{1-[2-(4-cycloheptylpiperazine-1-carbonyl)phenyl]piperidin-4-yl}-4-methoxybenzamide

V002-0923 Screening compound: N-{1-[2-(4-cycloheptylpiperazine-1-carbonyl)phenyl]piperidin-4-yl}-4-methoxybenzamide
V002-0923 Screening compound: N-{1-[2-(4-cycloheptylpiperazine-1-carbonyl)phenyl]piperidin-4-yl}-4-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-0923
N-{1-[2-(4-cycloheptylpiperazine-1-carbonyl)phenyl]piperidin-4-yl}-4-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-0923

Molecular Formula

C31H42N4O3 (C31 H42 N4 O3)

Compound Name

N-{1-[2-(4-cycloheptylpiperazine-1-carbonyl)phenyl]piperidin-4-yl}-4-methoxybenzamide

IUPAC name

N-{1-[2-(4-cycloheptylpiperazine-1-carbonyl)phenyl]piperidin-4-yl}-4-methoxybenzamide

SMILES

COc(cc1)ccc1C(NC(CC1)CCN1c(cccc1)c1C(N(CC1)CCN1C1CCCCCC1)=O)=O

InChI

InChI=1S/C31H42N4O3/c1-38-27-14-12-24(13-15-27)30(36)32-25-16-18-34(19-17-25)29-11-7-6-10-28(29)31(37)35-22-20-33(21-23-35)26-8-4-2-3-5-9-26/h6-7,10-15,25-26H,2-5,8-9,16-23H2,1H3,(H,32,36)

InChI Key

JWINCFSTYANLSV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19894665

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

518.7

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.428

Distribution Coefficient, logD

4.324

Water Solubility, LogSw

-4.25

Polar Surface Area

54.953

Acid Dissociation Constant (pKa)

14.56

Base Dissociation Constant (pKb)

6.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.80

V002-0923 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
Targets:
  • Proteases
  • Ion Channels

References: we are preparing a list of scientific research reports with V002-0923 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-0923?
Check Price and Availability of V002-0923, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-0923 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-0923
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-0923
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-0923 available by request